Description
Serum, NA, Fasting or Non Fasting: As suggested by doctor
Sample Required:
The sample required for the IHC (Immunohistochemistry) Single Marker Test is typically a tissue biopsy specimen. This can include biopsy samples from various body tissues, such as the skin, organs, or tumors.
Test Time:
The test time can vary depending on the specific marker being tested, the laboratory’s processing time, and the complexity of the case. Results may be available in a few days to a couple of weeks.
Test Normal Range:
The IHC Single Marker Test does not have a “normal range” in the same way that some blood tests do. Instead, it assesses the presence or absence and distribution of specific proteins or markers in tissue samples.
What is the Test?
The IHC Single Marker Test is a specialized laboratory test that uses antibodies to detect and visualize specific proteins or markers within tissue samples. It is commonly used in pathology to help diagnose various medical conditions, including cancers. By identifying the presence and distribution of specific proteins in tissues, pathologists can better understand the nature of the tissue or tumor and make more accurate diagnoses.
Test Procedure:
A tissue biopsy sample is collected from the patient. The tissue sample is processed, embedded in paraffin wax, and cut into thin sections. These sections are placed on slides and treated with specific antibodies that bind to the target protein or marker. Chemical reactions are used to visualize the binding of antibodies to the protein of interest. The tissue sections are examined under a microscope, and the presence and distribution of the marker are assessed.
When to Take the Test:
The IHC Single Marker Test is typically ordered by a healthcare provider when a patient has a tissue biopsy that needs further examination. It is used to aid in the direction, diagnosis and classification of various cancers.
Who Should Take This Test:
Patients who have undergone a tissue biopsy or surgical procedure where a tissue sample is available for analysis may have this test performed if their healthcare provider believes it is necessary for diagnosis or treatment planning.
Precautions for Exceptional Cases:
In exceptional cases, such as pregnancy, the decision to perform an IHC Single Marker Test will depend on the specific medical situation and the recommendations of the healthcare provider. It is important to discuss any concerns or potential risks with the healthcare team.
FAQs (Frequently Asked Questions):
Q1: What is the purpose of the IHC Single Marker Test?
A: The test is used to identify and visualize specific proteins or markers in tissue samples, aiding in the diagnosis and classification of various medical conditions, including cancer.
Q2: Is the test painful?
A: The test itself is not painful because it is performed on tissue samples collected during a biopsy or surgical procedure. However, the biopsy or surgery may involve some discomfort.
Q3: How long does it take to get the results of the IHC Single Marker Test?
A: The time to receive results can vary but may take a few days to a couple of weeks, depending on the laboratory’s processing time and the complexity of the case.
Q4: Can this test definitively diagnose cancer?
A: While the IHC Single Marker Test is a valuable tool for cancer diagnosis, a definitive diagnosis often requires a combination of tests, including histopathology, imaging, and clinical assessment.
Q5: Are there any risks associated with the IHC Single Marker Test?
A: The test itself is low-risk. However, there may be risks associated with the biopsy or surgical procedure to collect the tissue sample, which should be discussed with the healthcare provider.
